Evidence map›Paper›PMID 17037572›Full record

ArticleAdvances in experimental medicine and biology2006

Identification of the receptor for FGL2 and implications for susceptibility to mouse hepatitis virus (MHV-3)-induced fulminant hepatitis.

Hao Liu, Li Zhang, Myron Cybulsky, Reg Gorczynski, Jennifer Crookshank, Justin Manuel, David Grant, Gary Levy

2 registry-linked trialsAbstract read
In one paragraph

Article in Advances in experimental medicine and biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00606528 completednot on this mapstarted 2008, after this paper: background citation

FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy

TypeobservationalSponsorUniversity Health Network, TorontoRan2008Enrolled54ConditionsChronic Hepatitis C Virus InfectionArmsNo intervention
NCT00701272 unknown statusnot on this mapstarted 2008, after this paper: background citation

FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of HCV Recurrence and Progression Post Liver Transplantation

TypeobservationalSponsorUniversity Health Network, TorontoRan2008 to 2014Enrolled70ConditionsLiver Transplantation, Hepatitis C
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hao LiuMulti Organ Transplant Program, University Health Network, University of Toronto, Canada.
Li Zhang
Myron Cybulsky
Reg Gorczynski
Jennifer Crookshank
Justin Manuel
David Grant
Gary Levy
University of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADP-ribosyl Cyclase 1AnimalsCell LineCoronavirus InfectionsCricetinaeFibrinogenLiver Failure, AcuteMiceMice, Inbred C57BLMurine hepatitis virusProtein BindingReceptors, IgGSpecies SpecificitySpleenADP-ribosyl Cyclase 1Fgl2 protein, mouseFibrinogenReceptors, IgG

Identifiers

PMID17037572
PMCPMC7123298
OpenAlexW2204250788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.